PATENT CLAIM ANALYSIS

Application Number: 15872498
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "158100"]

Abstract:
Described are single domain antibodies with a specificity for BACE1. More specifically, described are single variable-domain antibodies derived from camelids that bind to BACE1 and are capable of inhibiting the activity of BACE1. The antibodies can be used for research and medical applications. Specific applications include the use of BACE1-specific antibodies for the treatment of Alzheimer's disease.

Claim (Index 12):
A medicament comprising: the single domain antibody of  claim 10 ; and at least one pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.46512
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14023586', '12736389', '13377508', '15234649', '14292461']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7365672397099828
- 35 USC 102 Novelty (BERT): 0.526319186596593
- Combined Prediction Score: 0.7155424343986438
- Mean Citation Score: 266.514898
- Max Citation Score: 341.05063
- Similarity Product: 263.95950299989937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test